Your browser doesn't support javascript.
loading
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.
Sartore-Bianchi, Andrea; Pietrantonio, Filippo; Lonardi, Sara; Mussolin, Benedetta; Rua, Francesco; Crisafulli, Giovanni; Bartolini, Alice; Fenocchio, Elisabetta; Amatu, Alessio; Manca, Paolo; Bergamo, Francesca; Tosi, Federica; Mauri, Gianluca; Ambrosini, Margherita; Daniel, Francesca; Torri, Valter; Vanzulli, Angelo; Regge, Daniele; Cappello, Giovanni; Marchiò, Caterina; Berrino, Enrico; Sapino, Anna; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto.
Afiliação
  • Sartore-Bianchi A; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy.
  • Pietrantonio F; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Lonardi S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Mussolin B; Medical Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS Padua, Padua, Italy.
  • Rua F; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Crisafulli G; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Bartolini A; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Fenocchio E; Department of Oncology, University of Turin, Turin, Italy.
  • Amatu A; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Manca P; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Bergamo F; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Tosi F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Mauri G; Medical Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS Padua, Padua, Italy.
  • Ambrosini M; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Daniel F; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy.
  • Torri V; IFOM, FIRC Institute of Molecular Oncology, Milan, Italy.
  • Vanzulli A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Regge D; Medical Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS Padua, Padua, Italy.
  • Cappello G; Mario Negri Institute for Pharmacological Research-IRCCS, Milan, Italy.
  • Marchiò C; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale), Milan, Italy.
  • Berrino E; Department of Services, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Sapino A; Department of Surgical Sciences, University of Turin, Turin, Italy.
  • Marsoni S; Unit of Radiology, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Siena S; Unit of Radiology, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Bardelli A; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
Nat Med ; 28(8): 1612-1618, 2022 08.
Article em En | MEDLINE | ID: mdl-35915157
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo / DNA Tumoral Circulante / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo / DNA Tumoral Circulante / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália